DYAZIDE
- Product NDC
- 0007-3650
- 11-digit product format
- 000073650
- Labeler code
- 0007
- Product ID
- 0007-3650_f19ff7cb-9829-4a43-97b6-157da265b982
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- hydrochlorothiazide and triamterene
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- GlaxoSmithKline LLC
- Application
- NDA016042
- Marketing category
- NDA
- Marketing start
- 1994-03-30
- Marketing end
- 2021-09-30
- Substance
- HYDROCHLOROTHIAZIDE; TRIAMTERENE
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0007-3650-22 | 00007365022 | 100 CAPSULE in 1 BOTTLE (0007-3650-22) | 100 capsule | 1994-03-30 | 0000-00-00 | No | No | Current |